New vaccine aims to fight childhood brain tumors without surgery
Disease control
Recruiting now
This phase 2 trial tests a vaccine made from glioma antigen peptides combined with an immune booster (Poly-ICLC) in 25 children with recurrent low-grade gliomas that cannot be removed by surgery. The goal is to see if the vaccine can shrink tumors or keep them stable. Children wh…
Phase: PHASE2 • Sponsor: James Felker • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC